Question special
Lead Moderator

I appreciate the various responses from the panel of experts raising very interesting points on the various proposed mechanisms of Liraglutide on weight loss and the discussion we had on very important issues on medication adherence and compliance as well the dropout and LOCF values for weight loss.

We started some discussion on adverse events and side effects of Liraglutide yesterday. I was wondering if the experts and authors could comment further about whether we should be concerned with the slight increase signal we can see for occurrence of pancreatitis and the raised levels of amylase and lipase levels in the Liraglutide group.